Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
2–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female from 2 to \<12 years of age.
Require treatment for the prevention of systemic fungal infection.
Expected to develop neutropenia (ANC \<500 cells/μL) lasting more than 10 days following chemotherapy.
Anticipated to live for more than 3 months.
You may not be if
Evidence of any clinically significant liver or renal function or other abnormalities such as cardiac arrhythmia, hypokalemia, hypomagnesemia or hypocalcemia.
Documented bacterial or viral infection not responding to appropriate treatment.
Hypersensitivity to or severe intolerance of azole antifungal agents.
Receiving other azoles or drugs that is are prohibited in the voriconazole label or associated.
Clareo Health | Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection
